Gene Symbol | Gene ID | Gene Info |
---|---|---|
SPIC
|
ENSG00000166211.6 | Spi-C transcription factor |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_37017654_37018643 | 5.84 |
COX6A1P2 |
cytochrome c oxidase subunit VIa polypeptide 1 pseudogene 2 |
5541 |
0.22 |
chr10_11212951_11213685 | 4.63 |
RP3-323N1.2 |
|
21 |
0.98 |
chr19_49838375_49839003 | 3.97 |
CD37 |
CD37 molecule |
5 |
0.95 |
chr7_106505707_106506635 | 3.90 |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
247 |
0.95 |
chr7_26333293_26333815 | 3.69 |
SNX10 |
sorting nexin 10 |
880 |
0.67 |
chr4_38763469_38763952 | 3.40 |
ENSG00000222230 |
. |
3197 |
0.22 |
chr15_80262648_80263745 | 3.34 |
BCL2A1 |
BCL2-related protein A1 |
315 |
0.89 |
chr3_151922835_151923340 | 3.28 |
MBNL1 |
muscleblind-like splicing regulator 1 |
62742 |
0.13 |
chr12_69742009_69742310 | 3.25 |
LYZ |
lysozyme |
5 |
0.97 |
chr6_114130917_114131144 | 3.17 |
ENSG00000253091 |
. |
28363 |
0.16 |
chr20_4802726_4803481 | 3.13 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
1188 |
0.5 |
chr2_158298330_158298802 | 3.07 |
ENSG00000216054 |
. |
504 |
0.79 |
chr1_244215744_244215895 | 3.06 |
ZBTB18 |
zinc finger and BTB domain containing 18 |
1234 |
0.51 |
chr12_51717169_51717830 | 3.03 |
BIN2 |
bridging integrator 2 |
400 |
0.82 |
chrX_30594869_30596024 | 3.00 |
CXorf21 |
chromosome X open reading frame 21 |
515 |
0.84 |
chr19_6481304_6482171 | 3.00 |
DENND1C |
DENN/MADD domain containing 1C |
27 |
0.95 |
chr18_77166229_77166515 | 2.94 |
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
5980 |
0.26 |
chr5_101630775_101631018 | 2.93 |
SLCO4C1 |
solute carrier organic anion transporter family, member 4C1 |
1357 |
0.46 |
chr7_50345819_50346403 | 2.91 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
1733 |
0.5 |
chr16_29756168_29756400 | 2.90 |
AC009133.17 |
|
284 |
0.75 |
chr22_40858602_40858925 | 2.87 |
MKL1 |
megakaryoblastic leukemia (translocation) 1 |
659 |
0.7 |
chr9_117690832_117691467 | 2.84 |
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8 |
1548 |
0.52 |
chr17_29635054_29635205 | 2.84 |
EVI2B |
ecotropic viral integration site 2B |
5973 |
0.14 |
chr18_5515397_5515794 | 2.83 |
EPB41L3 |
erythrocyte membrane protein band 4.1-like 3 |
5827 |
0.21 |
chr1_158802859_158803010 | 2.78 |
MNDA |
myeloid cell nuclear differentiation antigen |
1827 |
0.35 |
chr7_50727890_50728167 | 2.75 |
GRB10 |
growth factor receptor-bound protein 10 |
33401 |
0.21 |
chr11_67171589_67172183 | 2.73 |
TBC1D10C |
TBC1 domain family, member 10C |
226 |
0.8 |
chr1_236118295_236118523 | 2.72 |
ENSG00000206803 |
. |
39694 |
0.15 |
chr3_172240144_172241280 | 2.72 |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
553 |
0.83 |
chrX_16829271_16829422 | 2.70 |
TXLNG |
taxilin gamma |
24791 |
0.15 |
chr1_26869491_26869642 | 2.63 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
37 |
0.97 |
chr2_175498105_175498391 | 2.61 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
1059 |
0.58 |
chr19_2084034_2084229 | 2.59 |
MOB3A |
MOB kinase activator 3A |
1260 |
0.31 |
chr4_26887523_26887909 | 2.57 |
STIM2 |
stromal interaction molecule 2 |
24635 |
0.21 |
chrX_131121415_131121857 | 2.54 |
ENSG00000265686 |
. |
9237 |
0.22 |
chr19_42082478_42082785 | 2.54 |
CEACAM21 |
carcinoembryonic antigen-related cell adhesion molecule 21 |
30 |
0.97 |
chr1_150736206_150736357 | 2.52 |
CTSS |
cathepsin S |
1987 |
0.25 |
chr21_36881466_36881794 | 2.52 |
ENSG00000211590 |
. |
211383 |
0.02 |
chr12_57870254_57870608 | 2.51 |
ARHGAP9 |
Rho GTPase activating protein 9 |
1136 |
0.26 |
chr19_7413904_7414409 | 2.51 |
CTB-133G6.1 |
|
308 |
0.88 |
chr17_29646389_29646953 | 2.48 |
CTD-2370N5.3 |
|
822 |
0.44 |
chr16_19524952_19525190 | 2.46 |
GDE1 |
glycerophosphodiester phosphodiesterase 1 |
3419 |
0.15 |
chr11_33915442_33916212 | 2.45 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
1991 |
0.35 |
chr5_171602218_171602369 | 2.44 |
STK10 |
serine/threonine kinase 10 |
13097 |
0.19 |
chr2_198172097_198172605 | 2.44 |
ANKRD44 |
ankyrin repeat domain 44 |
3160 |
0.2 |
chr19_16477276_16478284 | 2.42 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
5016 |
0.17 |
chr11_5713127_5713492 | 2.40 |
TRIM22 |
tripartite motif containing 22 |
1052 |
0.38 |
chr10_114135452_114136486 | 2.38 |
ACSL5 |
acyl-CoA synthetase long-chain family member 5 |
12 |
0.98 |
chr18_43747886_43748286 | 2.36 |
C18orf25 |
chromosome 18 open reading frame 25 |
5433 |
0.22 |
chr5_126144250_126144473 | 2.34 |
LMNB1 |
lamin B1 |
31480 |
0.19 |
chr21_39748147_39748387 | 2.34 |
KCNJ15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
79419 |
0.11 |
chrX_4827603_4827754 | 2.33 |
ENSG00000222834 |
. |
190723 |
0.03 |
chr8_66863582_66864279 | 2.32 |
DNAJC5B |
DnaJ (Hsp40) homolog, subfamily C, member 5 beta |
69865 |
0.12 |
chr22_37680309_37680627 | 2.32 |
CYTH4 |
cytohesin 4 |
1940 |
0.3 |
chr7_100181255_100181941 | 2.30 |
FBXO24 |
F-box protein 24 |
7 |
0.93 |
chr19_39108076_39108634 | 2.29 |
MAP4K1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
209 |
0.87 |
chr7_3134520_3134947 | 2.28 |
CARD11 |
caspase recruitment domain family, member 11 |
51154 |
0.14 |
chr3_81873946_81874241 | 2.28 |
GBE1 |
glucan (1,4-alpha-), branching enzyme 1 |
62781 |
0.16 |
chr3_13056686_13056902 | 2.27 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
28258 |
0.23 |
chr13_46752006_46752233 | 2.26 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
4340 |
0.19 |
chrX_12991784_12992037 | 2.26 |
TMSB4X |
thymosin beta 4, X-linked |
1317 |
0.51 |
chr5_39201497_39202174 | 2.26 |
FYB |
FYN binding protein |
1294 |
0.59 |
chr2_99327229_99327528 | 2.25 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
15781 |
0.22 |
chr3_101441272_101441423 | 2.24 |
CEP97 |
centrosomal protein 97kDa |
1422 |
0.34 |
chr3_128951042_128951193 | 2.23 |
COPG1 |
coatomer protein complex, subunit gamma 1 |
17332 |
0.14 |
chr2_197032904_197033284 | 2.23 |
STK17B |
serine/threonine kinase 17b |
2630 |
0.28 |
chr4_78114724_78115069 | 2.22 |
CCNG2 |
cyclin G2 |
35317 |
0.18 |
chr6_154568354_154568864 | 2.21 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
53 |
0.99 |
chr4_87930432_87930664 | 2.21 |
AFF1 |
AF4/FMR2 family, member 1 |
2127 |
0.43 |
chr18_2970989_2971515 | 2.21 |
RP11-737O24.1 |
|
4236 |
0.18 |
chr10_129848775_129848926 | 2.19 |
PTPRE |
protein tyrosine phosphatase, receptor type, E |
3016 |
0.36 |
chr5_39178009_39178205 | 2.19 |
FYB |
FYN binding protein |
25022 |
0.23 |
chr19_36400134_36400285 | 2.19 |
TYROBP |
TYRO protein tyrosine kinase binding protein |
1012 |
0.33 |
chr13_51466419_51466869 | 2.19 |
RNASEH2B-AS1 |
RNASEH2B antisense RNA 1 |
866 |
0.61 |
chr3_117147285_117147436 | 2.18 |
ENSG00000206889 |
. |
115692 |
0.07 |
chr21_46340531_46340791 | 2.17 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
109 |
0.73 |
chr6_143140776_143141820 | 2.17 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
16886 |
0.26 |
chr16_50715070_50715234 | 2.15 |
SNX20 |
sorting nexin 20 |
71 |
0.96 |
chr17_43487096_43487739 | 2.15 |
ARHGAP27 |
Rho GTPase activating protein 27 |
335 |
0.82 |
chr15_83513837_83513988 | 2.14 |
HOMER2 |
homer homolog 2 (Drosophila) |
4567 |
0.18 |
chr7_152209916_152210186 | 2.12 |
ENSG00000221454 |
. |
73745 |
0.08 |
chr4_141163908_141164258 | 2.12 |
SCOC |
short coiled-coil protein |
14357 |
0.21 |
chr3_121378552_121379115 | 2.11 |
HCLS1 |
hematopoietic cell-specific Lyn substrate 1 |
912 |
0.5 |
chr11_93451553_93451767 | 2.10 |
ENSG00000199875 |
. |
1109 |
0.22 |
chr8_134084504_134084857 | 2.09 |
SLA |
Src-like-adaptor |
12077 |
0.24 |
chr20_55004696_55004919 | 2.09 |
CASS4 |
Cas scaffolding protein family member 4 |
17490 |
0.12 |
chr4_88130454_88130941 | 2.08 |
KLHL8 |
kelch-like family member 8 |
10723 |
0.25 |
chr11_48066553_48066704 | 2.07 |
AC103828.1 |
|
29221 |
0.17 |
chr1_206749084_206749354 | 2.06 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
18726 |
0.14 |
chr12_111043580_111043895 | 2.06 |
TCTN1 |
tectonic family member 1 |
8095 |
0.15 |
chr13_41535439_41535590 | 2.04 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
20904 |
0.17 |
chr14_52329027_52329412 | 2.04 |
GNG2 |
guanine nucleotide binding protein (G protein), gamma 2 |
1177 |
0.52 |
chr5_100116126_100116278 | 2.04 |
ENSG00000221263 |
. |
36067 |
0.19 |
chr19_2281673_2281974 | 2.03 |
C19orf35 |
chromosome 19 open reading frame 35 |
352 |
0.73 |
chr1_158255764_158255947 | 2.01 |
CD1C |
CD1c molecule |
3721 |
0.22 |
chr15_65592203_65592532 | 2.00 |
ENSG00000199568 |
. |
3978 |
0.15 |
chr20_55059093_55059344 | 2.00 |
ENSG00000238294 |
. |
8519 |
0.13 |
chr2_45794731_45794926 | 2.00 |
SRBD1 |
S1 RNA binding domain 1 |
326 |
0.88 |
chr6_119661299_119661487 | 1.99 |
MAN1A1 |
mannosidase, alpha, class 1A, member 1 |
9508 |
0.24 |
chr2_219235805_219236126 | 1.99 |
ENSG00000225062 |
. |
3407 |
0.11 |
chr7_50351765_50352753 | 1.99 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
3941 |
0.34 |
chr2_61211949_61212100 | 1.99 |
ENSG00000222251 |
. |
13863 |
0.17 |
chr3_36949362_36950295 | 1.99 |
TRANK1 |
tetratricopeptide repeat and ankyrin repeat containing 1 |
36720 |
0.16 |
chr1_22402292_22402667 | 1.98 |
CDC42-IT1 |
CDC42 intronic transcript 1 (non-protein coding) |
16789 |
0.13 |
chr5_67536077_67536613 | 1.97 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
619 |
0.81 |
chr1_200995010_200995304 | 1.96 |
KIF21B |
kinesin family member 21B |
2329 |
0.28 |
chr19_51920344_51920879 | 1.93 |
SIGLEC10 |
sialic acid binding Ig-like lectin 10 |
224 |
0.81 |
chr1_161591836_161592114 | 1.92 |
FCGR3B |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
8847 |
0.12 |
chr12_60014384_60014594 | 1.92 |
SLC16A7 |
solute carrier family 16 (monocarboxylate transporter), member 7 |
23649 |
0.19 |
chr16_58916272_58916423 | 1.92 |
ENSG00000244003 |
. |
111919 |
0.06 |
chrX_71321409_71321690 | 1.91 |
RGAG4 |
retrotransposon gag domain containing 4 |
30129 |
0.14 |
chr1_28195799_28196249 | 1.91 |
THEMIS2 |
thymocyte selection associated family member 2 |
3031 |
0.15 |
chr2_219031294_219031758 | 1.90 |
CXCR1 |
chemokine (C-X-C motif) receptor 1 |
192 |
0.92 |
chr1_29253197_29253478 | 1.90 |
EPB41 |
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
12246 |
0.18 |
chr7_150060956_150061224 | 1.87 |
REPIN1 |
replication initiator 1 |
4188 |
0.12 |
chr1_26316985_26317339 | 1.87 |
PAFAH2 |
platelet-activating factor acetylhydrolase 2, 40kDa |
6950 |
0.1 |
chr6_154567664_154567948 | 1.87 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
184 |
0.97 |
chr7_151548445_151549030 | 1.87 |
PRKAG2-AS1 |
PRKAG2 antisense RNA 1 |
25390 |
0.14 |
chr12_65143392_65143687 | 1.86 |
GNS |
glucosamine (N-acetyl)-6-sulfatase |
3112 |
0.19 |
chr17_76907300_76907451 | 1.86 |
CTD-2373H9.5 |
|
8030 |
0.14 |
chr14_75989073_75989329 | 1.86 |
BATF |
basic leucine zipper transcription factor, ATF-like |
298 |
0.91 |
chr6_391719_392776 | 1.86 |
IRF4 |
interferon regulatory factor 4 |
508 |
0.87 |
chr12_47609896_47610314 | 1.86 |
PCED1B |
PC-esterase domain containing 1B |
53 |
0.98 |
chr2_173379052_173379229 | 1.86 |
AC093818.1 |
|
1902 |
0.31 |
chr2_197103959_197104132 | 1.85 |
AC020571.3 |
|
20703 |
0.17 |
chr7_72408094_72408320 | 1.85 |
RP11-313P13.5 |
|
12544 |
0.1 |
chr3_107851409_107852101 | 1.84 |
CD47 |
CD47 molecule |
41883 |
0.19 |
chr1_151130840_151130991 | 1.83 |
SCNM1 |
sodium channel modifier 1 |
1775 |
0.16 |
chr5_124049414_124049565 | 1.83 |
RP11-436H11.2 |
|
15035 |
0.13 |
chr12_25207113_25207806 | 1.82 |
LRMP |
lymphoid-restricted membrane protein |
1785 |
0.37 |
chr1_161038546_161039545 | 1.82 |
ARHGAP30 |
Rho GTPase activating protein 30 |
411 |
0.65 |
chr6_30798000_30798388 | 1.81 |
ENSG00000202241 |
. |
33833 |
0.07 |
chr15_59978569_59978942 | 1.81 |
RP11-361D15.2 |
|
1961 |
0.25 |
chr16_23864221_23864482 | 1.81 |
PRKCB |
protein kinase C, beta |
15807 |
0.23 |
chr14_75885513_75886422 | 1.81 |
RP11-293M10.6 |
|
8426 |
0.2 |
chr4_6919832_6920181 | 1.81 |
TBC1D14 |
TBC1 domain family, member 14 |
8031 |
0.18 |
chr22_38791219_38791718 | 1.80 |
CSNK1E |
casein kinase 1, epsilon |
3059 |
0.17 |
chr9_101899616_101899767 | 1.80 |
ENSG00000252942 |
. |
8557 |
0.19 |
chr11_85852372_85852523 | 1.80 |
ENSG00000200877 |
. |
11822 |
0.22 |
chr12_109029005_109029265 | 1.79 |
RP11-689B22.2 |
|
490 |
0.66 |
chr6_64062753_64063151 | 1.79 |
LGSN |
lengsin, lens protein with glutamine synthetase domain |
33070 |
0.23 |
chr16_50622993_50623235 | 1.78 |
RP11-401P9.6 |
|
24481 |
0.14 |
chr17_29136154_29136502 | 1.78 |
CRLF3 |
cytokine receptor-like factor 3 |
15361 |
0.12 |
chr4_85674539_85674690 | 1.78 |
WDFY3 |
WD repeat and FYVE domain containing 3 |
19999 |
0.22 |
chr13_48735840_48736070 | 1.78 |
MED4 |
mediator complex subunit 4 |
66688 |
0.1 |
chr7_150180608_150181504 | 1.77 |
GIMAP7 |
GTPase, IMAP family member 7 |
30862 |
0.13 |
chr1_241714988_241715186 | 1.77 |
KMO |
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
16848 |
0.2 |
chr16_31255451_31255602 | 1.77 |
ITGAM |
integrin, alpha M (complement component 3 receptor 3 subunit) |
15785 |
0.08 |
chr21_46322955_46323106 | 1.77 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
7515 |
0.11 |
chr12_8693614_8693765 | 1.77 |
CLEC4E |
C-type lectin domain family 4, member E |
130 |
0.95 |
chr22_40781561_40781851 | 1.77 |
RP5-1042K10.10 |
|
2515 |
0.24 |
chr1_111415583_111415734 | 1.77 |
CD53 |
CD53 molecule |
117 |
0.97 |
chr8_61798290_61798522 | 1.76 |
RP11-33I11.2 |
|
76241 |
0.12 |
chr7_25536183_25536351 | 1.76 |
ENSG00000222101 |
. |
74021 |
0.13 |
chr19_33863308_33863524 | 1.75 |
CEBPG |
CCAAT/enhancer binding protein (C/EBP), gamma |
820 |
0.64 |
chr7_73509063_73509569 | 1.75 |
LIMK1 |
LIM domain kinase 1 |
1907 |
0.33 |
chr2_24114630_24115019 | 1.75 |
ATAD2B |
ATPase family, AAA domain containing 2B |
24067 |
0.18 |
chr1_198633706_198634133 | 1.74 |
RP11-553K8.5 |
|
2271 |
0.37 |
chr16_89830973_89831469 | 1.74 |
FANCA |
Fanconi anemia, complementation group A |
19751 |
0.11 |
chr1_198620819_198621442 | 1.74 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
12838 |
0.23 |
chr3_117168587_117168738 | 1.74 |
ENSG00000206889 |
. |
94390 |
0.1 |
chr5_131803417_131803568 | 1.74 |
ENSG00000202533 |
. |
347 |
0.82 |
chr1_26872928_26873171 | 1.73 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
706 |
0.6 |
chr12_118796743_118797337 | 1.73 |
TAOK3 |
TAO kinase 3 |
69 |
0.98 |
chr17_33378351_33378574 | 1.73 |
ENSG00000238858 |
. |
3051 |
0.16 |
chr5_39274843_39275074 | 1.73 |
FYB |
FYN binding protein |
328 |
0.93 |
chr5_138850718_138851297 | 1.73 |
AC138517.1 |
Uncharacterized protein |
1101 |
0.4 |
chr17_29055552_29055754 | 1.73 |
SUZ12P |
|
3251 |
0.2 |
chr11_128596540_128596842 | 1.72 |
SENCR |
smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA |
30773 |
0.16 |
chr6_31583875_31584076 | 1.72 |
AIF1 |
allograft inflammatory factor 1 |
207 |
0.77 |
chr12_12163057_12163773 | 1.72 |
BCL2L14 |
BCL2-like 14 (apoptosis facilitator) |
39363 |
0.19 |
chr13_46751053_46751538 | 1.72 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
5164 |
0.18 |
chr8_134538484_134538635 | 1.71 |
ST3GAL1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
26933 |
0.25 |
chr6_108145054_108145346 | 1.71 |
SCML4 |
sex comb on midleg-like 4 (Drosophila) |
316 |
0.93 |
chr15_78374826_78374977 | 1.71 |
SH2D7 |
SH2 domain containing 7 |
4751 |
0.14 |
chr17_67499160_67499534 | 1.71 |
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
777 |
0.78 |
chr17_75424510_75424661 | 1.71 |
SEPT9 |
septin 9 |
1547 |
0.34 |
chr17_56365676_56365827 | 1.71 |
MPO |
myeloperoxidase |
7455 |
0.13 |
chrX_37640522_37640673 | 1.70 |
CYBB |
cytochrome b-245, beta polypeptide |
1280 |
0.54 |
chr22_37696666_37696924 | 1.70 |
CYTH4 |
cytohesin 4 |
9214 |
0.17 |
chr12_109025962_109026141 | 1.70 |
SELPLG |
selectin P ligand |
197 |
0.91 |
chr21_39869780_39870199 | 1.69 |
ERG |
v-ets avian erythroblastosis virus E26 oncogene homolog |
356 |
0.93 |
chr5_76152476_76152645 | 1.69 |
S100Z |
S100 calcium binding protein Z |
6636 |
0.18 |
chr6_116786373_116786594 | 1.69 |
RP1-93H18.6 |
|
1628 |
0.26 |
chr7_73625229_73625469 | 1.69 |
LAT2 |
linker for activation of T cells family, member 2 |
996 |
0.49 |
chr18_2658233_2658442 | 1.69 |
SMCHD1 |
structural maintenance of chromosomes flexible hinge domain containing 1 |
2451 |
0.24 |
chr4_40202041_40202542 | 1.68 |
RHOH |
ras homolog family member H |
327 |
0.9 |
chr11_75602925_75603176 | 1.68 |
UVRAG |
UV radiation resistance associated |
13602 |
0.14 |
chr16_89600841_89601123 | 1.67 |
ENSG00000252579 |
. |
1020 |
0.38 |
chr9_36144726_36145049 | 1.67 |
GLIPR2 |
GLI pathogenesis-related 2 |
8145 |
0.19 |
chr17_61778727_61779133 | 1.66 |
LIMD2 |
LIM domain containing 2 |
398 |
0.8 |
chr3_30688450_30688601 | 1.66 |
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa) |
40432 |
0.19 |
chrX_47489222_47489415 | 1.65 |
CFP |
complement factor properdin |
24 |
0.96 |
chr3_196281269_196281534 | 1.65 |
WDR53 |
WD repeat domain 53 |
12780 |
0.13 |
chr12_753148_753299 | 1.64 |
NINJ2 |
ninjurin 2 |
392 |
0.75 |
chr14_73932612_73932763 | 1.64 |
ENSG00000251393 |
. |
3558 |
0.18 |
chr1_161186968_161187119 | 1.64 |
FCER1G |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
1956 |
0.12 |
chr5_171267830_171268045 | 1.63 |
SMIM23 |
small integral membrane protein 23 |
55047 |
0.13 |
chr10_80059650_80059801 | 1.63 |
ENSG00000201393 |
. |
67539 |
0.14 |
chr2_175459196_175459684 | 1.63 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
3053 |
0.24 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.5 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
1.1 | 3.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.1 | 1.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
1.0 | 6.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
1.0 | 2.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.9 | 3.7 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.8 | 3.4 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.8 | 6.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.8 | 4.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.8 | 2.4 | GO:0032621 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.7 | 2.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.7 | 2.7 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.7 | 2.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.7 | 2.0 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.6 | 1.9 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.6 | 3.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.6 | 3.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.6 | 1.8 | GO:0001865 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.6 | 0.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.6 | 1.8 | GO:0033622 | integrin activation(GO:0033622) |
0.5 | 1.1 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.5 | 7.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 2.7 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.5 | 2.7 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.5 | 4.3 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.5 | 2.1 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.5 | 2.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.5 | 1.5 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.5 | 8.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.5 | 4.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 0.5 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.5 | 8.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.5 | 1.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.5 | 3.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.5 | 2.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.5 | 1.4 | GO:0010447 | response to acidic pH(GO:0010447) |
0.5 | 0.9 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.5 | 1.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 2.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.5 | 0.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.4 | 1.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.4 | 1.3 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.4 | 1.3 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.4 | 0.4 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.4 | 1.3 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.4 | 2.6 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.4 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.4 | 0.4 | GO:0002363 | alpha-beta T cell lineage commitment(GO:0002363) |
0.4 | 5.5 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.4 | 2.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.4 | 1.3 | GO:0002883 | hypersensitivity(GO:0002524) regulation of hypersensitivity(GO:0002883) |
0.4 | 2.0 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.4 | 1.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.4 | 3.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.4 | 1.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.4 | 0.8 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.4 | 1.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.4 | 0.4 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.4 | 1.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.4 | 3.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 0.4 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.4 | 2.9 | GO:0002532 | production of molecular mediator involved in inflammatory response(GO:0002532) |
0.4 | 0.4 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.4 | 1.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.4 | 0.4 | GO:0070339 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
0.4 | 1.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 1.7 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.3 | 1.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 0.3 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.3 | 1.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 2.8 | GO:0042119 | neutrophil activation(GO:0042119) |
0.3 | 1.0 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.3 | 5.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.3 | 1.4 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.3 | 1.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 0.3 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.3 | 1.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.3 | 0.7 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.3 | 1.0 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.3 | 1.3 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 1.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.3 | 1.6 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.3 | 1.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 1.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.3 | 3.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 1.6 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.3 | 1.3 | GO:0035987 | endodermal cell fate commitment(GO:0001711) endodermal cell differentiation(GO:0035987) |
0.3 | 0.3 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.3 | 0.6 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.3 | 0.9 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 0.6 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.3 | 0.6 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.3 | 1.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.9 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.3 | 4.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.3 | 1.2 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.3 | 1.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 0.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.3 | 0.9 | GO:0009405 | pathogenesis(GO:0009405) |
0.3 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 0.6 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.3 | 1.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 0.9 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 0.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.3 | 1.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.3 | 0.9 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.3 | 0.8 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 4.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.3 | 0.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.3 | 0.8 | GO:0010761 | fibroblast migration(GO:0010761) |
0.3 | 0.6 | GO:0071436 | sodium ion export(GO:0071436) |
0.3 | 0.8 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.3 | 1.9 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.3 | 1.6 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.3 | 0.8 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.3 | 0.8 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) cilium movement involved in cell motility(GO:0060294) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 1.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.3 | 0.8 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 0.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 0.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.3 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.3 | 0.8 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.3 | 1.6 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.3 | 1.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.3 | 0.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 0.8 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 5.1 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.3 | 14.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.3 | 7.1 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.3 | 1.0 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.3 | 0.3 | GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043370) regulation of CD4-positive, alpha-beta T cell activation(GO:2000514) |
0.2 | 0.7 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.7 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.2 | 0.2 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.2 | 3.9 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 0.5 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.2 | 0.5 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.2 | 1.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 0.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 1.2 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.2 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.2 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.2 | 1.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 3.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.7 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.7 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 2.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.7 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.2 | 1.3 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.2 | 3.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 0.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 0.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 1.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 1.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 1.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.2 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.2 | 0.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.7 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 1.7 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.2 | 4.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 1.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.4 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 0.2 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.2 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.2 | 0.2 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 1.8 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 0.6 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
0.2 | 1.4 | GO:0006911 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.2 | 0.6 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.2 | 0.8 | GO:1904376 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.6 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.2 | 1.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.2 | 2.0 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 2.0 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.2 | 0.8 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.2 | 0.4 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 1.9 | GO:0032615 | interleukin-12 production(GO:0032615) |
0.2 | 2.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.4 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.2 | 0.6 | GO:0035610 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.2 | 0.2 | GO:0043301 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.2 | 1.5 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.2 | 0.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 0.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.2 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) regulation of mesoderm development(GO:2000380) |
0.2 | 0.4 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.2 | 0.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.2 | 1.8 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.2 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.2 | 0.2 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.2 | 0.5 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 1.5 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 2.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 0.4 | GO:0061054 | dermatome development(GO:0061054) |
0.2 | 0.5 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.2 | 0.5 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.2 | 0.7 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 0.2 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.2 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.5 | GO:0031060 | regulation of histone methylation(GO:0031060) regulation of histone H3-K4 methylation(GO:0051569) |
0.2 | 0.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.2 | 0.4 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.2 | 2.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.9 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.2 | 0.2 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 0.2 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.2 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 3.5 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.2 | 0.7 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.5 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.5 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.2 | 1.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.7 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.7 | GO:0044146 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) negative regulation of growth of symbiont in host(GO:0044130) modulation of growth of symbiont involved in interaction with host(GO:0044144) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.2 | 0.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 0.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 1.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 0.3 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 1.5 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.2 | 0.8 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.2 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 0.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 1.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.5 | GO:0070265 | necrotic cell death(GO:0070265) |
0.2 | 1.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.2 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.2 | 1.8 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.2 | 0.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 2.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.5 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 1.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 1.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.6 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.2 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 0.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 1.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.9 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.2 | 0.6 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 0.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 0.5 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.2 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.9 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.2 | 0.2 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.2 | 0.3 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.2 | 0.2 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.2 | 0.3 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.2 | 0.3 | GO:0046471 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.2 | 0.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 1.8 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.2 | 1.5 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.2 | 0.8 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.1 | GO:1903427 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of reactive oxygen species biosynthetic process(GO:1903427) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.7 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 1.6 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.1 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
0.1 | 2.8 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.7 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.7 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.1 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.1 | 0.7 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.4 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 1.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.1 | 1.9 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.8 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 3.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.6 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.1 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 1.3 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.1 | 1.5 | GO:0044766 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.3 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.4 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.1 | 1.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.4 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.7 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 1.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 1.1 | GO:0048002 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) antigen processing and presentation of peptide antigen(GO:0048002) |
0.1 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.1 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 0.1 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.1 | 0.3 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 4.6 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.7 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.4 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.4 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 2.0 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.8 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.4 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.6 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.9 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 0.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.1 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.1 | 0.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.8 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.1 | 0.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 1.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 16.4 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 1.0 | GO:0042098 | T cell proliferation(GO:0042098) |
0.1 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.5 | GO:0016233 | telomere capping(GO:0016233) |
0.1 | 0.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.4 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.5 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 1.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 1.6 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 1.2 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.1 | 0.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.5 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.5 | GO:0042116 | macrophage activation(GO:0042116) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 1.1 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.5 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.4 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.6 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.1 | 1.9 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 1.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 1.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.1 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.1 | 1.3 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.2 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.1 | 0.6 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 0.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.2 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 6.0 | GO:0072395 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 1.2 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 3.0 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.2 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.3 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.9 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.1 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.1 | 0.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.6 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.1 | 0.2 | GO:0032892 | positive regulation of organic acid transport(GO:0032892) |
0.1 | 0.2 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 1.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 1.5 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 1.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.1 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
0.1 | 0.4 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.1 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.3 | GO:0010898 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.3 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 1.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.9 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.5 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.4 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.1 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 2.8 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.1 | 0.6 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 1.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.2 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.1 | 2.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0046931 | pore complex assembly(GO:0046931) |
0.1 | 0.7 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 1.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 5.7 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.5 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.1 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.8 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.1 | 0.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.2 | GO:1904377 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.2 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 4.0 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 0.2 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 1.3 | GO:0042113 | B cell activation(GO:0042113) |
0.1 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 36.0 | GO:0006955 | immune response(GO:0006955) |
0.1 | 1.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 1.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.3 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 2.1 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.1 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.7 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 6.5 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.3 | GO:0043474 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.1 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.4 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 4.8 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.1 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.1 | 0.2 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.1 | 0.3 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 2.2 | GO:0070486 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.1 | 0.1 | GO:0060206 | histamine secretion(GO:0001821) estrous cycle phase(GO:0060206) |
0.1 | 0.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.7 | GO:0046649 | lymphocyte activation(GO:0046649) |
0.1 | 0.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 1.1 | GO:0050812 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.4 | GO:0007004 | telomere maintenance via telomerase(GO:0007004) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.6 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 0.7 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 1.0 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.1 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.1 | 0.2 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.1 | 1.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.3 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.9 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 | 0.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.8 | GO:0051099 | positive regulation of binding(GO:0051099) |
0.1 | 1.4 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.4 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.7 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 1.3 | GO:0016236 | macroautophagy(GO:0016236) |
0.1 | 0.6 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.5 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.3 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.3 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.4 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.3 | GO:0051322 | anaphase(GO:0051322) |
0.1 | 2.6 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 1.8 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.9 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.1 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.1 | 0.1 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 0.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 2.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.1 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.2 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.1 | 0.5 | GO:0015904 | tetracycline transport(GO:0015904) |
0.1 | 0.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.3 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 1.6 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.9 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 1.7 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.1 | 0.1 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.1 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.4 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.5 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 0.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.7 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.1 | 1.4 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.1 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.1 | 0.2 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 3.8 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.7 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.1 | GO:0051284 | negative regulation of calcium-mediated signaling(GO:0050849) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 1.3 | GO:0007033 | vacuole organization(GO:0007033) |
0.1 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.2 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 1.9 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.3 | GO:0042436 | tryptophan catabolic process(GO:0006569) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.3 | GO:0009208 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.1 | 2.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 1.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.1 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 2.9 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.5 | GO:0042752 | regulation of circadian rhythm(GO:0042752) |
0.1 | 0.9 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 0.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.2 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.6 | GO:0034968 | peptidyl-lysine methylation(GO:0018022) histone lysine methylation(GO:0034968) |
0.1 | 0.3 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.3 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.3 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.3 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.2 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.1 | 0.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.3 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 1.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 5.1 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 0.4 | GO:0098657 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.1 | 0.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.2 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.2 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.4 | GO:0007159 | leukocyte cell-cell adhesion(GO:0007159) |
0.1 | 1.8 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.3 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.1 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.1 | 0.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.1 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.1 | 0.4 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.3 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
0.1 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.6 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.1 | 0.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.3 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.2 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.0 | 1.5 | GO:0048193 | Golgi vesicle transport(GO:0048193) |
0.0 | 0.0 | GO:0044403 | symbiosis, encompassing mutualism through parasitism(GO:0044403) |
0.0 | 0.0 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 7.2 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 1.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 0.4 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.3 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.0 | 4.5 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.0 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.0 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.0 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.1 | GO:0032782 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.0 | 0.1 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.0 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.1 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.0 | 0.0 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 1.0 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.0 | 0.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.2 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.2 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 2.1 | GO:0044033 | multi-organism metabolic process(GO:0044033) |
0.0 | 1.1 | GO:0009206 | ATP biosynthetic process(GO:0006754) ribonucleoside triphosphate biosynthetic process(GO:0009201) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
0.0 | 0.1 | GO:1903555 | regulation of tumor necrosis factor superfamily cytokine production(GO:1903555) |
0.0 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 2.4 | GO:0016072 | rRNA processing(GO:0006364) rRNA metabolic process(GO:0016072) |
0.0 | 0.4 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.0 | 0.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.5 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.1 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 0.3 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.0 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) negative regulation of T cell apoptotic process(GO:0070233) regulation of thymocyte apoptotic process(GO:0070243) negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.4 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 1.6 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.0 | GO:0033483 | gas homeostasis(GO:0033483) |
0.0 | 0.0 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.0 | 0.2 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.0 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.0 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 0.0 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.1 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 2.9 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.0 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.0 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.1 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.0 | GO:0072205 | collecting duct development(GO:0072044) metanephric collecting duct development(GO:0072205) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.0 | 0.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.0 | 0.0 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.0 | 0.0 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 0.1 | GO:0050906 | detection of stimulus involved in sensory perception(GO:0050906) |
0.0 | 0.1 | GO:0035315 | hair cell differentiation(GO:0035315) auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.1 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.0 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.2 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.0 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.4 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.0 | 0.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.0 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.1 | GO:0007622 | rhythmic behavior(GO:0007622) |
0.0 | 0.1 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.0 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.1 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.0 | GO:0015851 | nucleobase transport(GO:0015851) |
0.0 | 0.1 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.4 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.1 | GO:0014904 | myotube cell development(GO:0014904) skeletal muscle fiber development(GO:0048741) |
0.0 | 0.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.0 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.0 | 0.2 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.1 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:0097435 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.0 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.1 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0045143 | synapsis(GO:0007129) homologous chromosome segregation(GO:0045143) chromosome organization involved in meiotic cell cycle(GO:0070192) |
0.0 | 0.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.0 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.0 | GO:0072665 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.8 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.0 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.0 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.0 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.0 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.0 | 0.0 | GO:0034766 | negative regulation of ion transmembrane transport(GO:0034766) |
0.0 | 0.0 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.0 | GO:0043543 | protein acylation(GO:0043543) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.0 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0033345 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.9 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.0 | 0.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.7 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) |
0.0 | 0.0 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.0 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.0 | 0.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.1 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.0 | 0.0 | GO:0098543 | detection of other organism(GO:0098543) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.0 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.0 | GO:0070723 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0021940 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.0 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.0 | GO:0046131 | pyrimidine ribonucleoside metabolic process(GO:0046131) |
0.0 | 0.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.8 | 7.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.7 | 7.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.6 | 1.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.6 | 3.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.6 | 2.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.6 | 8.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.5 | 2.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 1.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.4 | 1.3 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 1.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.4 | 1.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.4 | 2.9 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.4 | 1.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 1.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 0.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 0.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 3.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 0.9 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 1.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 1.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 0.5 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.3 | 1.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 1.0 | GO:0001740 | Barr body(GO:0001740) |
0.3 | 1.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 5.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 1.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.2 | GO:0000792 | heterochromatin(GO:0000792) |
0.2 | 2.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.7 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 1.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.5 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 0.7 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 0.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 1.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.8 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 1.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.2 | GO:0005652 | lamin filament(GO:0005638) nuclear lamina(GO:0005652) |
0.2 | 0.6 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.2 | 2.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 2.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 1.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 1.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 1.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 0.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 1.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 1.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 0.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.2 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 2.4 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.8 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 1.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 0.6 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 17.6 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 1.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 1.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 4.3 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 2.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 2.8 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 4.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.4 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.1 | 1.6 | GO:0005768 | endosome(GO:0005768) |
0.1 | 0.5 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 3.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 1.6 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 3.8 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 3.8 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 1.1 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 3.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 1.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.6 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.7 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 19.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 4.5 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 2.8 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 21.3 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.4 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 1.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 1.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.1 | GO:0030313 | outer membrane-bounded periplasmic space(GO:0030288) cell envelope(GO:0030313) periplasmic space(GO:0042597) |
0.1 | 3.5 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 1.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 4.0 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 5.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.9 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.7 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 1.3 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.1 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 0.5 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.2 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 1.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 5.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 1.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 1.5 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 3.7 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 5.0 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.7 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 3.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 1.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.2 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.1 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 2.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.2 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.4 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.2 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 0.6 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 6.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 1.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 1.1 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 3.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.4 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.4 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.5 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 95.3 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 1.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 1.0 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.1 | GO:0000123 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 1.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 1.0 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 3.4 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 40.7 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.4 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.3 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 1.3 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.4 | GO:0046930 | membrane attack complex(GO:0005579) pore complex(GO:0046930) |
0.1 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.1 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.0 | 0.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.0 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 1.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.8 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 2.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.2 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.1 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0098573 | integral component of mitochondrial membrane(GO:0032592) intrinsic component of mitochondrial membrane(GO:0098573) |
0.0 | 0.8 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.0 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.6 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 1.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 2.3 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 1.5 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 8.0 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.0 | 9.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.2 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 1.9 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.1 | GO:0044454 | nuclear chromosome part(GO:0044454) |
0.0 | 0.3 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.0 | 0.8 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 4.2 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 2.9 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.2 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 15.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 1.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.8 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 2.3 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.1 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.1 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 0.0 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.7 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.1 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 1.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.1 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.0 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 68.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.5 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 2.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.0 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 21.0 | GO:0005737 | cytoplasm(GO:0005737) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 7.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.3 | 3.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.1 | 3.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.9 | 2.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.8 | 2.5 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.8 | 3.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.8 | 2.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.7 | 5.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.7 | 2.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.7 | 5.4 | GO:0005522 | profilin binding(GO:0005522) |
0.7 | 2.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.6 | 5.5 | GO:0019864 | IgG binding(GO:0019864) |
0.5 | 1.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 1.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.5 | 6.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.5 | 8.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.5 | 2.0 | GO:0005534 | galactose binding(GO:0005534) |
0.5 | 1.9 | GO:0004340 | glucokinase activity(GO:0004340) |
0.5 | 1.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 1.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 1.9 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 2.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.5 | 0.9 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.5 | 4.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.5 | 1.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.5 | 1.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.5 | 4.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.4 | 1.3 | GO:0004875 | complement receptor activity(GO:0004875) |
0.4 | 1.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 1.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 1.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.4 | 1.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 4.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.4 | 1.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.4 | 1.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.4 | 1.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.4 | 1.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 0.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 1.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.4 | 1.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 1.1 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.3 | 1.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 2.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 2.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 1.0 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.3 | 2.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 6.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 2.0 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.3 | 1.6 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 1.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 1.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 1.0 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.3 | 1.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 1.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 1.8 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 0.3 | GO:0019863 | IgE binding(GO:0019863) |
0.3 | 1.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 2.7 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.3 | 1.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 3.0 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.3 | 1.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 0.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 4.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 0.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 2.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.3 | 1.7 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 1.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 2.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 1.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 0.8 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.3 | 1.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 0.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 0.8 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 0.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 1.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 2.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 0.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 4.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.2 | 1.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 0.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 0.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 3.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 1.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 3.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 0.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 1.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.2 | 3.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 1.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.4 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.2 | 0.9 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 5.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 1.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 0.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 2.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 1.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 0.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 1.0 | GO:0015923 | mannosidase activity(GO:0015923) |
0.2 | 1.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 1.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.2 | 1.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 0.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 1.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 3.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 2.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.7 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.9 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.2 | 2.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 1.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 4.0 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.2 | 11.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 1.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 2.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 1.0 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 1.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 2.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.5 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.2 | 0.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.4 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 0.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.3 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.2 | 3.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 0.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.5 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 0.9 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 1.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 1.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 2.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 1.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.4 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 1.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.4 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.1 | 0.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.7 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 2.0 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 1.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 3.7 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 3.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 1.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 1.7 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.5 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.4 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 1.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 2.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 1.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 1.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.4 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 2.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 5.6 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.6 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 1.6 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 1.0 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 2.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 2.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.9 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.7 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.3 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 0.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 2.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.2 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 2.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 2.9 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.6 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 3.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 1.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 4.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.1 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 4.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.7 | GO:0043566 | chromatin DNA binding(GO:0031490) structure-specific DNA binding(GO:0043566) |
0.1 | 0.4 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.6 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.5 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.1 | 0.5 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 18.0 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 1.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 1.0 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 1.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 1.0 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 2.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.2 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.1 | 0.3 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 1.1 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.9 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 1.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 2.6 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 3.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 3.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.2 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 1.0 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.1 | GO:0004396 | hexokinase activity(GO:0004396) |
0.1 | 0.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 5.1 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 1.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.6 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 1.3 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.2 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.1 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.1 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 1.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 5.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.9 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.6 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 2.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.1 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.1 | 0.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.5 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.4 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.1 | 0.2 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 2.9 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.6 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 2.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.8 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 13.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 19.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.5 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.1 | 0.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.8 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 1.2 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.9 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 2.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.5 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 1.2 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.2 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.0 | 0.9 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 2.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.3 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.4 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.0 | 0.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 1.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.4 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 2.4 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 1.4 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.8 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.0 | 0.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.7 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 1.0 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.3 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) potassium ion antiporter activity(GO:0022821) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.0 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 1.5 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 5.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.8 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.7 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 2.9 | GO:0050662 | coenzyme binding(GO:0050662) |
0.0 | 1.0 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 9.3 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.7 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.2 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.0 | 0.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.2 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.2 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.5 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.7 | GO:0031267 | small GTPase binding(GO:0031267) |
0.0 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.2 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.6 | GO:0016407 | acetyltransferase activity(GO:0016407) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.7 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.2 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 6.2 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.0 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 3.8 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.0 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.0 | 5.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 1.5 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.2 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.7 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.4 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.0 | 0.0 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.2 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.1 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 12.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.6 | 15.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.5 | 15.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.5 | 4.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 24.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.5 | 5.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 0.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 5.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 4.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 4.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 8.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 9.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 5.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 10.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 7.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 5.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 2.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 9.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 4.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 3.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 0.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 7.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 3.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 1.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 1.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 8.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 3.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 1.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 4.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 5.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 1.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 7.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 1.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 0.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 1.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 9.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 2.7 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 1.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 3.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 4.1 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 3.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 2.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 2.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 2.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 2.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 3.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 2.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.5 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 4.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 3.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.6 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 1.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 6.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 14.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 8.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 1.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.5 | 6.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 13.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.4 | 6.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 0.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 6.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 8.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.4 | 4.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 4.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.4 | 4.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 1.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 7.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 10.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 5.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 0.9 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.3 | 4.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 0.3 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.3 | 3.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 2.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 1.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 1.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.3 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 1.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 3.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 2.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 3.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 7.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 0.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 12.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 3.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 0.9 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 7.2 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.2 | 3.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 1.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 3.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 3.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 1.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 3.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 2.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 5.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 9.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 0.4 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.2 | 0.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.2 | 1.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 2.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 5.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 2.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 2.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 5.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 3.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 1.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 2.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 1.0 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.2 | 1.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 2.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 2.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 1.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 3.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 7.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 2.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 4.1 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 6.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 3.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 2.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 3.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 6.0 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.1 | 1.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 1.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 2.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 4.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 6.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 1.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 1.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 2.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 4.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 4.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 3.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.5 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 2.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.0 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 2.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 3.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.4 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 7.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 2.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 2.3 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 1.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 1.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 1.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.5 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 1.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 2.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 2.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.2 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.0 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 4.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |